These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment. Benson MD; Smith RA; Hung G; Kluve-Beckerman B; Showalter AD; Sloop KW; Monia BP Amyloid; 2010 Jun; 17(2):43-9. PubMed ID: 20462362 [TBL] [Abstract][Full Text] [Related]
3. The molecular biology and clinical features of amyloid neuropathy. Benson MD; Kincaid JC Muscle Nerve; 2007 Oct; 36(4):411-23. PubMed ID: 17554795 [TBL] [Abstract][Full Text] [Related]
4. Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy. Ackermann EJ; Guo S; Booten S; Alvarado L; Benson M; Hughes S; Monia BP Amyloid; 2012 Jun; 19 Suppl 1():43-4. PubMed ID: 22494066 [TBL] [Abstract][Full Text] [Related]
5. Inconsistency between hepatic expression and serum concentration of transthyretin in mice humanized at the transthyretin locus. Zhao G; Li Z; Araki K; Haruna K; Yamaguchi K; Araki M; Takeya M; Ando Y; Yamamura K Genes Cells; 2008 Dec; 13(12):1257-68. PubMed ID: 19032346 [TBL] [Abstract][Full Text] [Related]
6. [Gene therapy in familial amyloidotic polyneuropathy by single-stranded oligonucleotides (SSOs)]. Nakamura M; Ando Y Rinsho Byori; 2004 Oct; 52(10):804-12. PubMed ID: 15624495 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid. Eriksson M; Büttner J; Todorov T; Yumlu S; Schönland S; Hegenbart U; Kristen AV; Dengler T; Lohse P; Helmke B; Schmidt H; Röcken C Am J Surg Pathol; 2009 Jan; 33(1):58-65. PubMed ID: 18830126 [TBL] [Abstract][Full Text] [Related]
14. In vivo stabilization of mutant human transthyretin in transgenic mice. Tagoe CE; Reixach N; Friske L; Mustra D; French D; Gallo G; Buxbaum JN Amyloid; 2007 Sep; 14(3):227-36. PubMed ID: 17701470 [TBL] [Abstract][Full Text] [Related]
15. Transgenic mouse model of familial amyloidotic polyneuropathy. Shimada K; Maeda S; Murakami T; Nishiguchi S; Tashiro F; Yi S; Wakasugi S; Takahashi K; Yamamura K Mol Biol Med; 1989 Aug; 6(4):333-43. PubMed ID: 2560117 [TBL] [Abstract][Full Text] [Related]
16. A transgenic mouse line developed to express human amyloidogenic transthyretin cDNA in the brain. Ohuchi K; Matsuda A; Maeda S; Shimada K; Miyakawa T Biochem Int; 1991 Mar; 23(5):809-17. PubMed ID: 1715703 [TBL] [Abstract][Full Text] [Related]
18. Effect of tacrolimus and partial hepatectomy on transthyretin metabolism in rats. Zeledon R ME; Ando Y; Asonuma K; Nakamura M; Sun X; Ueda M; Fujii J; Inomata Y Transpl Int; 2006 Mar; 19(3):233-8. PubMed ID: 16441773 [TBL] [Abstract][Full Text] [Related]
19. Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis. Liepnieks JJ; Wilson DL; Benson MD Amyloid; 2006 Sep; 13(3):170-7. PubMed ID: 17062384 [TBL] [Abstract][Full Text] [Related]
20. Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation. Salvi F; Pastorelli F; Plasmati R; Ferlini A; Grazi GL; Jovine E; Mascalchi M; Tassinari CA Neurol Sci; 2005 Jun; 26(2):140-2. PubMed ID: 15995833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]